Notice Type
Departmental
Notice Title

Corrigendum—Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health granted consent to the distribution in New Zealand of the new medicine listed in the Schedule to a notice published in the New Zealand Gazette, 15 August 2019, Notice 2019-go3775.

This corrigendum amends the notice by replacing the entries:

Product:

Paracetamol + Ibuprofen

Active Ingredients:

Paracetamol 500mgIbuprofen 200mg

Dosage Form:

Film coated Tablet

New Zealand Sponsor:

PSM Healthcare Limited trading as API Consumer Brands

Manufacturer:

Medreich Limited, Bangalore, India

 

 

Product:

Tobramycin Wockhardt

Active Ingredient:

Tobramycin 300mg

Dosage Form:

Solution for inhalation

New Zealand Sponsor:

InterPharma (NZ) Limited

Manufacturers:

Holopack Verpackungstechnik GmbH, Abstgmund-Untergroningen, Germany
Holopack Verpackungstechnik GmbH, Sulzback-Laufe, Germany

with

Product:

Paracetamol + Ibuprofen

Active Ingredients:

Paracetamol 500mg
Ibuprofen 200mg

Dosage Form:

Film coated Tablet

New Zealand Sponsor:

PSM Healthcare Limited trading as API Consumer Brands

Manufacturer:

Medreich Limited, Bangalore, India

 

 

Product:

Tobramycin Wockhardt

Active Ingredient:

Tobramycin 300mg

Dosage Form:

Solution for inhalation

New Zealand Sponsor:

InterPharma Pty Limited, c/- Healthcare Logistics

Manufacturers:

Holopack Verpackungstechnik GmbH, Abstgmund-Untergroningen, Germany
Holopack Verpackungstechnik GmbH, Sulzback-Laufe, Germany


Dated this 21st day of August 2019.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).